Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$6.28 +0.84 (+15.34%)
At close: Nov 11, 2026 · 4:00 PM EST

Phathom Pharmaceuticals (PHAT) Other Accumulated Expenses (2019 - 2026)

Updated

Phathom Pharmaceuticals' Other Accumulated Expenses was $6.93 million in Q2 2026, up 42.3% from $4.87 million a year earlier and up 23.5% from the prior quarter.

Analysis

Phathom Pharmaceuticals (PHAT) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Phathom Pharmaceuticals came in at $7.5 million, up 146.4% from FY2024.

  • Other Accumulated Expenses shows a five-year compound annual growth rate of 197.8% (FY2020 to FY2025).
  • In earlier years, Other Accumulated Expenses was $3.04 million in FY2024, $117,000 in FY2023 (-22.5%), $151,000 in FY2022 (+268.3%) and $41,000 in FY2021 (+28.1%).
  • Quarterly Other Accumulated Expenses has moved between $20,000 (Q3 2023) and $7.5 million (Q4 2025) over five years.
  • Compared with a year earlier, Other Accumulated Expenses has increased for five straight quarters, with growth averaging 168.4% over the last six quarters.
  • The best year-over-year quarter for Other Accumulated Expenses over five years was Q2 2025 (growth of 570.9%); the worst was Q2 2023 (a decline of 46.2%).
  • Per Business Quant data, PHAT's Other Accumulated Expenses in the three quarters before Q2 2026 was $5.61 million (Q1 2026), $7.5 million (Q4 2025) and $4.79 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Phathom Pharmaceuticals 442.66 Mn -246.70 Mn 66.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.63 Mn
Jun 30, 2026 6.93 Mn
Mar 31, 2026 5.61 Mn
Dec 31, 2025 7.50 Mn
Sep 30, 2025 4.79 Mn
Jun 30, 2025 4.87 Mn
Mar 31, 2025 2.81 Mn
Dec 31, 2024 3.04 Mn
Sep 30, 2024 1.79 Mn
Jun 30, 2024 726,000.00
Mar 31, 2024 3.35 Mn
Dec 31, 2023 117,000.00
Sep 30, 2023 20,000.00
Jun 30, 2023 21,000.00
Mar 31, 2023 56,000.00
Dec 31, 2022 151,000.00
Sep 30, 2022 31,000.00
Jun 30, 2022 39,000.00
Mar 31, 2022 59,000.00
Dec 31, 2021 41,000.00
API Access

Phathom Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PHAT&period=max&api_key=YOUR_API_KEY